pinaverium 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
quaternary ammonium compounds 2174 59995-65-2

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • pinaverium
  • pinaverium bromide
  • Molecular weight: 511.52
  • Formula: C26H41BrNO4
  • CLOGP: 5.39
  • LIPINSKI: 2
  • HAC: 5
  • HDO: 0
  • TPSA: 36.92
  • ALOGS: -8.20
  • ROTB: 10

Drug dosage:

DoseUnitRoute
0.15 g O

ADMET properties:

PropertyValueReference
S (Water solubility) 16 mg/mL Bocci G, Oprea TI, Benet LZ
BDDCS (Biopharmaceutical Drug Disposition Classification System) 1 Bocci G, Oprea TI, Benet LZ

Approvals:

None

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Heart sounds 148.94 40.27 25 1505 971 63486521
Prolonged expiration 146.55 40.27 25 1505 1071 63486421
Depressive symptom 113.63 40.27 25 1505 4077 63483415
Respiration abnormal 107.62 40.27 26 1504 6391 63481101
Appetite disorder 104.21 40.27 26 1504 7295 63480197
Sleep disorder due to a general medical condition 91.08 40.27 26 1504 12162 63475330
Rales 85.58 40.27 25 1505 12672 63474820
Flank pain 83.44 40.27 26 1504 16384 63471108
Angina pectoris 68.01 40.27 26 1504 30052 63457440
Depressed mood 60.72 40.27 26 1504 40165 63447327
Stress 59.47 40.27 30 1500 67137 63420355
Rhinorrhoea 57.21 40.27 29 1501 65548 63421944
Productive cough 52.36 40.27 27 1503 63181 63424311
Nasal congestion 51.39 40.27 27 1503 65633 63421859
Asthma 51.10 40.27 34 1496 127527 63359965
Injury 48.62 40.27 27 1503 73220 63414272
Dyspnoea exertional 47.76 40.27 25 1505 60277 63427215
Wheezing 44.46 40.27 28 1502 95567 63391925
Chest discomfort 43.27 40.27 29 1501 109940 63377552
Upper respiratory tract infection 43.15 40.27 26 1504 82021 63405471
Influenza 41.16 40.27 28 1502 108694 63378798

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Heart sounds 144.42 36.74 24 1765 942 79741657
Prolonged expiration 137.84 36.74 24 1765 1247 79741352
Appetite disorder 99.59 36.74 25 1764 7714 79734885
Respiration abnormal 99.43 36.74 25 1764 7763 79734836
Depressive symptom 99.07 36.74 24 1765 6399 79736200
Sleep disorder due to a general medical condition 84.43 36.74 25 1764 14252 79728347
Flank pain 76.32 36.74 25 1764 19819 79722780
Rales 72.11 36.74 24 1765 19977 79722622
Rhinorrhoea 57.93 36.74 30 1759 76044 79666555
Depressed mood 54.62 36.74 25 1764 48455 79694144
Angina pectoris 53.07 36.74 25 1764 51707 79690892
Stress 51.04 36.74 28 1761 79584 79663015
Injury 48.97 36.74 27 1762 77469 79665130
Asthma 46.69 36.74 32 1757 135063 79607536
Nasal congestion 46.53 36.74 26 1763 76526 79666073
Productive cough 43.07 36.74 26 1763 88305 79654294
Upper respiratory tract infection 42.31 36.74 26 1763 91142 79651457
Chest discomfort 39.16 36.74 29 1760 138015 79604584
Dyspnoea exertional 38.29 36.74 24 1765 87049 79655550

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC A03AX04 ALIMENTARY TRACT AND METABOLISM
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
Other drugs for functional gastrointestinal disorders
MeSH PA D002121 Calcium Channel Blockers
MeSH PA D000077264 Calcium-Regulating Hormones and Agents
MeSH PA D002317 Cardiovascular Agents
MeSH PA D049990 Membrane Transport Modulators
MeSH PA D010276 Parasympatholytics
MeSH PA D018373 Peripheral Nervous System Agents

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
D07094 KEGG_DRUG
C0071081 UMLSCUI
CHEBI:135811 CHEBI
CHEMBL1909324 ChEMBL_ID
DB09090 DRUGBANK_ID
C013199 MESH_SUPPLEMENTAL_RECORD_UI
53251-94-8 SECONDARY_CAS_RN
U2368VVE7O UNII
40704 PUBCHEM_CID
33724 RXNORM
003872 NDDF
003873 NDDF
698023008 SNOMEDCT_US
CHEMBL1909298 ChEMBL_ID
3696 INN_ID

Pharmaceutical products:

None